Angelos Kyriacou
Overview
Explore the profile of Angelos Kyriacou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kyriacou A, Syed A, Sawicka-Gutaj N, Picolos M, Economides P, Kyriacou A
Clin Endocrinol (Oxf)
. 2022 Dec;
98(5):738-740.
PMID: 36574980
No abstract available.
2.
Ioakim S, Syed A, Zavros G, Picolos M, Persani L, Kyriacou A
Eur Thyroid J
. 2022 Oct;
11(6).
PMID: 36215117
Background: The 2015 American Thyroid Association (ATA) Guidelines recommend the following size cut-offs based on sonographic appearances for subjecting nodules to fine-needle aspiration (FNA) biopsy: low risk: 15 mm and...
3.
Papaetis G, Kyriacou A
Adv Clin Exp Med
. 2022 Aug;
31(11):1265-1274.
PMID: 35951627
Polycystic ovary syndrome (PCOS) is a disorder that involves several organ systems and cellular pathways. It is strongly influenced by environmental and epigenetic factors. The principal goal of all therapeutic...
4.
Sawicka-Gutaj N, Erampamoorthy A, Zybek-Kocik A, Kyriacou A, Zgorzalewicz-Stachowiak M, Czarnywojtek A, et al.
Metabolites
. 2022 Apr;
12(4).
PMID: 35448523
Nowadays obesity becomes a significant global problem. Hence, recently more and more attention has been paid to substances present in the body that have a significant impact on metabolic processes...
5.
Kyriacou A, Tziaferi V, Toumba M
Horm Res Paediatr
. 2022 Apr;
96(1):44-53.
PMID: 35385843
Stress is a potential catalyst for thyroid dysregulation through cross-communication of the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid (HPT) axes. Stress and stressors exposure motivates molecular mechanisms affecting compound feedback loops of the...
6.
Ragavan S, Elhelw O, Majeed W, Kyriacou A, Syed A
Cureus
. 2022 Apr;
14(3):e22751.
PMID: 35371892
Alemtuzumab, a humanized monoclonal antibody used as a disease-modifying treatment in relapsing-remitting multiple sclerosis (RRMS), frequently causes autoimmunity as its principal adverse effect. We describe a typical case of a...
7.
Kyriacou A, Ioakim S, Syed A
Eur J Intern Med
. 2021 Oct;
94:95-96.
PMID: 34690055
No abstract available.
8.
Mundy-Baird G, Kyriacou A, Syed A
CMAJ
. 2021 Oct;
193(39):E1549-E1550.
PMID: 34607853
No abstract available.
9.
Ioakim S, Constantinides V, Toumba M, Lyssiotis T, Kyriacou A
Endocrinol Diabetes Metab Case Rep
. 2021 Sep;
2021.
PMID: 34515657
Summary: Our objective is to demonstrate the importance of considering microcalcifications even without evidence of nodules as a potential sign of malignancy. Current guidelines, such as those of the British...
10.
Mundy-Baird G, Kyriacou A, Syed A
CMAJ
. 2021 Jul;
193(26):E1007.
PMID: 34226265
No abstract available.